Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -5.44%5.77B | 2.05%5.63B | -0.57%5.2B | 1.93%22.26B | 4.43%5.4B | -3.75%6.11B | 1.70%5.52B | 6.94%5.23B | 31.87%21.83B | 10.58%5.18B |
| Operating revenue | -6.34%5.48B | 1.23%5.28B | -1.65%4.58B | 2.09%20.75B | 4.63%5.02B | -3.65%5.85B | 1.79%5.22B | 7.67%4.66B | 31.11%20.33B | 10.28%4.8B |
| Cost of revenue | 9.15%4.34B | 2.85%4.18B | 1.80%4.24B | 7.12%16.8B | 11.14%4.59B | 1.97%3.98B | 9.92%4.07B | 5.39%4.17B | 13.97%15.68B | 7.55%4.13B |
| Gross profit | -32.71%1.43B | -0.21%1.45B | -9.90%956M | -11.30%5.46B | -22.11%814M | -12.89%2.13B | -15.92%1.45B | 13.48%1.06B | 120.04%6.15B | 24.40%1.05B |
| Operating expense | 5.51%1.15B | 4.56%1.03B | 1.33%1.06B | 8.29%4.19B | 10.56%1.07B | 5.84%1.09B | 6.59%986M | 10.29%1.05B | 29.81%3.87B | 11.29%966M |
| Selling and administrative expenses | -2.66%512M | 1.83%502M | 1.11%457M | 4.96%1.73B | -53.94%181M | 17.41%526M | 25.77%493M | 7.88%452M | 30.59%1.65B | 10.70%393M |
| -Selling and marketing expense | -5.52%274M | 2.23%275M | -0.38%265M | -1.09%1.09B | 2.77%260M | -5.54%290M | 1.89%269M | -2.56%266M | 37.64%1.1B | 10.96%253M |
| -General and administrative expense | 0.85%238M | 1.34%227M | 3.23%192M | 16.94%649M | -156.43%-79M | 67.38%236M | 75.00%224M | 27.40%186M | 18.59%555M | 10.24%140M |
| Other operating expenses | 13.17%636M | 7.30%529M | 1.51%607M | 10.77%2.46B | 54.80%887M | -3.10%562M | -7.50%493M | 12.20%598M | 29.24%2.22B | 11.70%573M |
| Operating profit | -72.69%284M | -10.30%418M | -1,081.82%-108M | -44.58%1.26B | -421.52%-254M | -26.50%1.04B | -41.90%466M | 164.71%11M | 1,318.72%2.28B | 382.14%79M |
| Net non-operating interest income (expenses) | -96.49%-112M | -24.68%-96M | -5.88%-90M | 41.63%-300M | 25.00%-81M | 52.50%-57M | 40.31%-77M | 45.86%-85M | 29.40%-514M | 36.09%-108M |
| Non-operating interest income | -64.91%40M | -39.18%59M | -40.00%75M | 3.61%431M | -12.84%95M | -3.39%114M | -8.49%97M | 50.60%125M | 147.62%416M | 53.52%109M |
| Non-operating interest expense | -11.11%152M | -10.92%155M | -21.43%165M | -21.40%731M | -18.89%176M | -28.15%171M | -25.96%174M | -12.50%210M | 3.79%930M | -9.58%217M |
| Other net income (expenses) | 494.19%339M | -1,560.00%-219M | 244.44%31M | -200.22%-448M | -355.63%-386M | -490.91%-86M | -87.80%15M | -94.04%9M | 173.40%447M | -55.98%151M |
| Gain on sale of security | 708.47%359M | -781.48%-184M | -38.57%43M | -173.81%-372M | -351.53%-410M | -247.50%-59M | -80.15%27M | -57.58%70M | 184.14%504M | -54.72%163M |
| Special income (charges) | --0 | --0 | --0 | 20.00%-8M | 3,900.00%38M | --0 | --0 | ---46M | 28.57%-10M | 96.77%-1M |
| -Less:Other special charges | ---- | ---- | ---- | -20.00%8M | -3,900.00%-38M | ---- | ---- | --46M | -28.57%10M | -96.77%1M |
| Other non-operating income (expenses) | 25.93%-20M | -191.67%-35M | 20.00%-12M | -44.68%-68M | -27.27%-14M | -145.45%-27M | -9.09%-12M | -7.14%-15M | -1,275.00%-47M | -178.57%-11M |
| Income before tax | -43.03%511M | -74.50%103M | -156.92%-167M | -76.72%515M | -690.98%-721M | -31.89%897M | -49.25%404M | -182.61%-65M | 245.14%2.21B | -16.44%122M |
| Income tax | 121.70%247M | -1,283.33%-83M | -506.25%-65M | -1,782.81%-1.21B | -24.19%-77M | -1,798.51%-1.14B | 85.71%-6M | 159.26%16M | -136.36%-64M | -181.82%-62M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -87.03%264M | -54.63%186M | -25.93%-102M | -24.43%1.72B | -450.00%-644M | 62.80%2.04B | -51.07%410M | -2,125.00%-81M | 233.88%2.28B | 9.52%184M |
| Net income continuous operations | -87.03%264M | -54.63%186M | -25.93%-102M | -24.43%1.72B | -450.00%-644M | 62.80%2.04B | -51.07%410M | -2,125.00%-81M | 233.88%2.28B | 9.52%184M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -87.03%264M | -54.63%186M | -25.93%-102M | -24.43%1.72B | -450.00%-644M | 62.80%2.04B | -51.07%410M | -2,125.00%-81M | 233.88%2.28B | 9.52%184M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -87.03%264M | -54.63%186M | -25.93%-102M | -24.43%1.72B | -450.00%-644M | 62.80%2.04B | -51.07%410M | -2,125.00%-81M | 233.88%2.28B | 9.52%184M |
| Diluted earnings per share | -84.33%0.89 | -49.12%0.58 | -40.91%-0.31 | -24.25%4.81 | -450.98%-1.79 | 62.75%5.68 | -51.28%1.14 | -2,300.00%-0.22 | 233.68%6.35 | 8.51%0.51 |
| Basic earnings per share | -83.64%0.88 | -50.96%0.51 | -81.82%-0.4 | -20.81%4.72 | -536.59%-1.79 | 74.68%5.38 | -55.56%1.04 | -633.33%-0.22 | 225.47%5.96 | -12.77%0.41 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.